Research · 20 Studies
LL-37
We track 20 published, PubMed-indexed studies for LL-37, spanning 2020 to 2026. The research below includes 20 reviews.
WhatPeptidesDoUpdated Jun 2026Reviewed
Key Takeaway
These summaries are for educational purposes. Research findings, particularly from preclinical studies, may not translate to human outcomes. Always consult a qualified healthcare provider before making decisions based on this information.
20 Reviews
LL-37 antimicrobial peptide: Molecular characterisation and its role in oral health and disease-A narrative review.
ReviewSoman D, P J, et al.|Arch Oral Biol|2026
LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity.
ReviewKeshri AK, Rawat SS, et al.|Int J Antimicrob Agents|2025
Cathelicidin LL-37 in periodontitis: current research advances and future prospects - A review.
ReviewHe Y, Zhou Y, et al.|Int Immunopharmacol|2025
Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats.
ReviewNeshani A, Zare H, et al.|Infect Genet Evol|2025
Human antimicrobial/host defense peptide LL-37 may prevent the spread of a local infection through multiple mechanisms: an update.
ReviewSvensson D, Nilsson BO|Inflamm Res|2025
Exploring the Antimicrobial Potential of LL-37 Derivatives: Recent Developments and Challenges.
ReviewYuan Y, Li J, et al.|ACS Biomater Sci Eng|2025
Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications.
ReviewVoronko OE, Khotina VA, et al.|Int J Mol Sci|2025
Cathelicidin expression in the pathogenesis of atopic dermatitis and the therapeutic potential of vitamin D.
ReviewConnell T, Seidler K, Neil J|Nutr Res|2025
Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease.
ReviewMiao S, Liu H, et al.|Pharmacol Res|2024
The LL-37 domain: A clue to cathelicidin immunomodulatory response?
ReviewLeite ML, Duque HM, et al.|Peptides|2023
Antibiofilm properties of cathelicidin LL-37: an in-depth review.
ReviewMemariani H, Memariani M|World J Microbiol Biotechnol|2023
Antifungal properties of cathelicidin LL-37: current knowledge and future research directions.
ReviewMemariani M, Memariani H|World J Microbiol Biotechnol|2023
Regulation of LL-37 in Bone and Periodontium Regeneration.
ReviewChinipardaz Z, Zhong JM, Yang S|Life (Basel)|2022
Cathelicidin LL-37 in Health and Diseases of the Oral Cavity.
ReviewTokajuk J, Deptuła P, et al.|Biomedicines|2022
Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis.
ReviewAloul KM, Nielsen JE, et al.|Front Immunol|2022
Antimicrobial Peptide, LL-37, And Its Potential As An Anti-HIV Agent.
ReviewVera-Cruz A, Tanphaichitr N, Angel JB|Clin Invest Med|2021
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent.
ReviewRidyard KE, Overhage J|Antibiotics (Basel)|2021
Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures.
ReviewZeth K, Sancho-Vaello E|Int J Mol Sci|2021
Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus.
ReviewMoreno-Angarita A, Aragón CC, Tobón GJ|J Transl Autoimmun|2020
Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections.
ReviewPahar B, Madonna S, et al.|Vaccines (Basel)|2020